Effect Doctors London Expands into Saudi Arabia with Launch of Cutting-Edge Wellness Centres

26-06-2025

Effect Doctors London, the UK's premier luxury wellness and medical service provider, has officially expanded its world-renowned operations to Saudi Arabia, bringing cutting-edge diagnostics, personalised vitamin IV therapies, and regenerative wellness services to the Kingdom's thriving health-conscious community.Having opened its first Saudi branch in January 2024 in North Riyadh and its second branch in March 2025, Effect Doctors London has quickly garnered an overwhelmingly positive response from local clients. 'We used to travel abroad to receive these services — now we are delighted they are available in Riyadh,' is a sentiment echoed by many early adopters. Building on this success, the brand is set to open two additional branches in Jeddah and Al Khobar within the next 30 days, ensuring nationwide accessibility.Strategic Entry into Saudi Arabia's Flourishing Wellness MarketEffect Doctors London's entry into Saudi Arabia follows a comprehensive evaluation of regional opportunities. 'Saudi Arabia stood out because of its remarkable advancements across health, wellness, and proactive healthcare development indicators,' said Dr. Will Turner, Co-Founder of Effect Doctors London.In alignment with the Kingdom's Vision 2030 goals for enhanced quality of life, Effect Doctors offers an innovative blend of science-backed wellness solutions adapted to the Saudi lifestyle, while preserving the brand's hallmark of medical excellence and luxury service.Flagship Services: Combining Science, Nature, and Personalised Human CareEffect Doctors' Saudi clients have access to a full range of premium services identical to those offered in London, including:• State-of-the-art Diagnostics: Comprehensive health assessments to map individual well-being.• Personalised IV Therapies: Treatments designed for energy enhancement, detoxification, skin health, and anti-ageing.• Longevity-Focused Treatments by avoiding lifestyle diseases: New services tailored to the region, emphasising healthy ageing and improved quality of life.Recently recognised as the Best IV Therapy and Wellness Provider by the MEA Business Awards, Effect Doctors holds a specialised IV Therapy Centre license from the Saudi Ministry of Health—the first of its kind in the Kingdom. The Riyadh flagship is complemented by a newly opened polyclinic, expanding services into aesthetics and further affirming the brand's commitment to holistic wellness.British Medical Pedigree: Setting Global Standards in Saudi ArabiaFounded by Dr. Will Turner and Dr. Will Buxton, both distinguished alumni of the UK's NHS system and Harley Street's elite medical circles, Effect Doctors maintains stringent international standards. While the founders do not practice directly in Saudi Arabia, they maintain a hands-on approach, regularly mentoring, training, and certifying the Riyadh team to ensure service excellence and scientific rigour.'Our protocols are universal—rooted in the human condition, scientific evidence, and the healing powers of nature—allowing us to seamlessly integrate into Saudi culture while maintaining world-class standards,' said Dr. Turner.Accessible Luxury for Saudi Arabia's Wellness PioneersPositioned as a provider of accessible luxury, Effect Doctors targets individuals who are proactively investing in their health and well-being. Transparency, privacy, and outstanding client experience are at the heart of the brand's growing success in the Kingdom.Effect Doctors is also proud to partner with the Saudi Commission for Health Specialties, providing exclusive wellness packages to healthcare professionals and their families as part of their shared mission to uplift community health standards.Looking Ahead: Building a Healthier, Longer-Living CommunityAs Effect Doctors continues to grow across Saudi Arabia, plans are underway to introduce next-generation diagnostics and longevity-focused therapies specifically tailored to regional health needs. 'We are committed to helping our community not just live longer—but live better,' affirmed Dr. Buxton.With its scientific excellence, personalised approach, and luxury wellness philosophy, Effect Doctors London is poised to redefine the healthcare and well-being landscape across the Kingdom and the wider GCC.
For more information, please visit: https://effectdoctorslondon.com/sa-en/

Hashtags

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

New Agreement Brings Breakthrough Dyslipidemia Treatment to Saudi Arabia and MEA

Syyaha

30-07-2025

Syyaha

New Agreement Brings Breakthrough Dyslipidemia Treatment to Saudi Arabia and MEA

Jamjoom Pharma, a leading Saudi pharmaceutical organization committed to enhancing the quality of life through the development, manufacturing, and distribution of high-quality medicines and consumer healthcare products across MEA, and Althera Laboratories, a company dedicated to developing and commercializing innovative therapies for cardiovascular and metabolic diseases, today announced a strategic licensing and supply agreement. This agreement is poised to address the growing need for effective dyslipidemia management in the region, contributing to better patient outcomes and cardiovascular this agreement, Jamjoom Pharma gets exclusive rights to commercialize in Saudi Arabia and non-exclusive rights for phased expansion across other MEA markets for Althera's fixed-dose combination of dual-action cholesterol-lowering therapy. The product launch in Saudi Arabia is targeted for 2027, with plans for phased expansion across MEA markets, subject to local regulatory collaboration marks a major milestone for both companies: Jamjoom strengthens its cardiovascular portfolio with a globally recognized and clinically effective therapy, while Althera expands its international footprint in a high-growth partnership aims to address the region's growing burden of cardiovascular diseases by increasing access to modern, affordable lipid-lowering treatment, to support patients across Tarek Hosni, CEO of Jamjoom Pharma, highlighted that: 'Cardiovascular diseases remain to be a leading health concern in Saudi Arabia and the wider MEA region, and this partnership enables us to provide patients across the MEA region with an innovative, evidence-based solution. Expanding access to effective cholesterol management aligns perfectly with our promise to deliver high-quality, affordable medications that improve lives.' Sanjeev Agarwal, CEO of Althera added 'This partnership with Jamjoom Pharma is a pivotal step for Althera, allowing us to extend our reach into the rapidly growing MENA region. We are confident that Jamjoom's deep market understanding and robust capabilities make them the perfect partner to deliver our Rproduct to healthcare providers and patients in Saudi Arabia and across MENA. This collaboration is a testament to our dedication to making innovative and affordable cardiovascular treatments more accessible globally.'

Naba Alsaha and Strataphy Partner to Launch One of Saudi Arabia's First Geothermal-Cooled Hospitals

Biz Bahrain

29-07-2025

Biz Bahrain

Naba Alsaha and Strataphy Partner to Launch One of Saudi Arabia's First Geothermal-Cooled Hospitals

In a pioneering step for sustainable healthcare infrastructure, Naba Alsaha Hospital, a leading Saudi healthcare group, has partnered with clean cooling innovator Strataphy to deploy advanced, subsurface-powered cooling systems for its new hospital complex in Riyadh, currently under construction. 'This project highlights how geothermal technology can meet the strict reliability and operational demands of the healthcare sector,' said Ahmed Alhani, COO of Strataphy. 'Hospitals require uninterrupted cooling performance around the clock. With our CAS model and subsurface technology, we're able to deliver that performance while significantly reducing grid impact and carbon emissions.' Saudi Arabia has more than 2,300 healthcare facilities across the Kingdom. With each facility requiring on average 1.5 megawatts-thermal (MW-th) of cooling capacity, the national healthcare sector represents a total thermal demand of approximately 3.45 gigawatts-thermal (GW-th). This places immense strain on the power grid and creates a clear opportunity for cleaner, more efficient solutions. At the heart of the system is Strataphy's PrimeLoop—a patent-pending geothermal hybrid architecture that uses subsurface temperatures to deliver continuous and efficient building cooling. Unlike traditional HVAC systems, which rely on electricity-intensive compressors and degrade in performance during high ambient temperatures, PrimeLoop operates silently and consistently, delivering a Coefficient of Performance (COP) over 5, more than double that of conventional methods. The solution is offered through Strataphy's Cooling as a Service (CAS) model—turning cooling from a costly CapEx decision into a monthly operating service. Strataphy handles design, drilling, installation, and long-term operations and maintenance, with clients only paying for actual cooling used. This removes technical and financial risk while improving ESG outcomes. 'As demand for high-performance medical infrastructure grows, we're proud to be among the first hospitals in the Kingdom to adopt this innovative, sustainable approach,' said Nayef Al-Jishi, Business Development Manager at Naba Alsaha Hospital. 'For us, it's about delivering long-term value to patients, operators, and the national grid. This partnership with Strataphy reinforces our commitment to future-ready, resilient, and environmentally aligned healthcare facilities.' 'This collaboration reflects a broader transformation underway across the Kingdom,' concluded Ammar Alali, CEO of Strataphy. 'The healthcare sector—with its 24/7 operational needs—is ideally suited to lead the geothermal cooling transition. We're proud to help power that shift and demonstrate how clean infrastructure can meet both performance and sustainability goals.'

Saudi's Game-Changer hospital eyes Global role

Daily Tribune

17-07-2025

Daily Tribune

Saudi's Game-Changer hospital eyes Global role

TDT | Manama King Faisal Specialist Hospital & Research Centre (KFSHRC) has been awarded Global Healthcare Accreditation (GHA) for Medical Travel Services, earning a 95 percent score that cements its role as a leader in Saudi Arabia's transformation into a global medical destination. The recognition reflects the Kingdom's shift from a historically outbound medical travel market to one now attracting international patients. In 2024 alone, KFSHRC treated individuals from 17 different countries, reinforcing its reputation as a trusted centre for complex, cross-border care. Trusted care The GHA certification, granted by a US-based body, evaluates hospitals on international standards that prioritise patient-centred care, cultural competence, care coordination, and post-treatment follow-up. KFSHRC's high score confirms its ability to deliver on all fronts. 'This accreditation affirms our commitment to providing international patients with exceptional care,' said Dr. Amaal AlDakheel, Director of International Healthcare Services at KFSHRC. 'The GHA process was more than a compliance exercise. It offered us deep reflection, professional exchange, and valuable learning that strengthened our readiness to serve the world.' Vision-driven shift Saudi Arabia's Vision 2030 calls for developing the country as a world-class hub for healthcare and medical tourism. KFSHRC is taking a lead in this goal by aiming to attract at least 5 percent of patients who would otherwise seek treatment abroad. Renée-Marie Stephano, CEO of Global Healthcare Accreditation, said KFSHRC reflects the bold ambition of this vision. 'Their commitment to excellence and global best practices exemplifies the future of safe, patient-centred international healthcare.' Cutting-edge capabilities To prepare for the accreditation, KFSHRC trained staff in GHA's methodology and standards. Several team members earned the Advanced Certified Medical Travel Professional designation, enhancing the hospital's ability to support diverse patient needs and expectations. KFSHRC also offers specialised care across eight Centres of Excellence covering cancer, transplant, neuroscience, heart, genome, surgery, paediatrics and women's health. Equipped with advanced technologies like CAR T-cell therapy and robotic surgery, it stands as one of the few institutions in the region offering such high-level treatments. The hospital was recently ranked 15th globally and first in the Middle East and Africa among the world's top 250 academic medical centres. It was also named the most valuable healthcare brand in the region by Brand Finance and included in Newsweek's list of the World's Best Smart Hospitals. Global network GHA is creating a broader international healthcare ecosystem by connecting accredited hospitals with insurers, referral partners, and travel providers. KFSHRC's inclusion in this network enhances its access to new markets, improves patient trust, and supports Saudi Arabia's ambition to become a preferred destination for medical travel. As one of the first in the region to achieve such a high standard, King Faisal Specialist Hospital is not only raising the bar for healthcare at home but also helping shape the Middle East's future as a trusted destination for advanced international treatment.